Operating
Increase (Decrease) in Deferred Income Taxes
Eli Lilly Increase (Decrease) in Deferred Income Taxes increased by 97.6% to $1.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 277.0%, from $392.00M to $1.48B. Over 3 years (FY 2021 to FY 2024), Increase (Decrease) in Deferred Income Taxes shows an upward trend with a 49.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests tax expenses were recorded but not yet paid, while a decrease indicates the utilization of deferred tax assets or payment of previously deferred liabilities.
Detailed definition
Represents the non-cash impact on operating cash flow resulting from timing differences between financial reporting and...
Peer comparison
Common across all capital-intensive industries; peers often show fluctuations based on tax legislation and capital investment cycles.
Metric ID:
operating_increase_decrease_in_deferred_income_taxesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $294.70M | $296.00M | $92.50M | $506.60M | $618.40M | $1.07B | $0.00 | $559.40M | $431.10M | $844.30M | $506.20M | $279.00M | $1.01B | $429.80M | $966.60M | $392.00M | $1.07B | $748.10M | $1.48B |
| QoQ Change | — | +0.4% | -68.8% | +447.7% | +22.1% | +73.1% | -100.0% | — | -22.9% | +95.8% | -40.0% | -44.9% | +261.1% | -57.3% | +124.9% | -59.4% | +172.5% | -30.0% | +97.6% |
| YoY Change | — | — | — | — | +109.8% | +261.7% | -100.0% | +10.4% | -30.3% | -21.1% | — | -50.1% | +133.7% | -49.1% | +91.0% | +40.5% | +6.0% | -22.6% | +277.0% |
Range$0.00 – $1.48B
CAGR+43.1%
Avg YoY Growth+46.9%
Median YoY Growth+8.2%
Increase (Decrease) in Deferred Income Taxes at Other Companies
Frequently Asked Questions
- What is Eli Lilly's increase (decrease) in deferred income taxes?
- Eli Lilly (LLY) reported increase (decrease) in deferred income taxes of $1.48B in Q1 2026.
- How has Eli Lilly's increase (decrease) in deferred income taxes changed year-over-year?
- Eli Lilly's increase (decrease) in deferred income taxes increased by 277.0% year-over-year, from $392.00M to $1.48B.
- What is the long-term trend for Eli Lilly's increase (decrease) in deferred income taxes?
- Over 3 years (2021 to 2024), Eli Lilly's increase (decrease) in deferred income taxes has grown at a 49.5% compound annual growth rate (CAGR), from $802.30M to $2.68B.
- What does increase (decrease) in deferred income taxes mean?
- The change in cash flow caused by differences between when taxes are recorded for accounting and when they are paid to authorities.